Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Downregulation of angiotensin-converting enzyme 2 by the neuraminidase protein of influenza A (H1N1) virus.

Liu X, Yang N, Tang J, Liu S, Luo D, Duan Q, Wang X.

Virus Res. 2014 Jun 24;185:64-71. doi: 10.1016/j.virusres.2014.03.010. Epub 2014 Mar 21.

PMID:
24662240
2.

Plasmin-mediated activation of pandemic H1N1 influenza virus hemagglutinin is independent of the viral neuraminidase.

Tse LV, Marcano VC, Huang W, Pocwierz MS, Whittaker GR.

J Virol. 2013 May;87(9):5161-9. doi: 10.1128/JVI.00210-13. Epub 2013 Feb 28.

3.

H1N1 influenza A virus neuraminidase modulates infectivity in mice.

Ferraris O, Escuret V, Bouscambert M, Casalegno JS, Jacquot F, Raoul H, Caro V, Valette M, Lina B, Ottmann M.

Antiviral Res. 2012 Mar;93(3):374-80. doi: 10.1016/j.antiviral.2012.01.008. Epub 2012 Feb 1.

PMID:
22321413
4.

Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.

Zou Z, Yan Y, Shu Y, Gao R, Sun Y, Li X, Ju X, Liang Z, Liu Q, Zhao Y, Guo F, Bai T, Han Z, Zhu J, Zhou H, Huang F, Li C, Lu H, Li N, Li D, Jin N, Penninger JM, Jiang C.

Nat Commun. 2014 May 6;5:3594. doi: 10.1038/ncomms4594.

PMID:
24800825
5.

The influenza virus neuraminidase protein transmembrane and head domains have coevolved.

da Silva DV, Nordholm J, Dou D, Wang H, Rossman JS, Daniels R.

J Virol. 2015 Jan 15;89(2):1094-104. doi: 10.1128/JVI.02005-14. Epub 2014 Nov 5.

6.

Characterization of the neuraminidase of the H1N1/09 pandemic influenza virus.

Gerlach T, Kühling L, Uhlendorff J, Laukemper V, Matrosovich T, Czudai-Matwich V, Schwalm F, Klenk HD, Matrosovich M.

Vaccine. 2012 Dec 7;30(51):7348-52. doi: 10.1016/j.vaccine.2012.09.078. Epub 2012 Oct 9.

PMID:
23063828
7.

Investigation of the binding and cleavage characteristics of N1 neuraminidases from avian, seasonal, and pandemic influenza viruses using saturation transfer difference nuclear magnetic resonance.

Garcia JM, Lai JC, Haselhorst T, Choy KT, Yen HL, Peiris JS, von Itzstein M, Nicholls JM.

Influenza Other Respir Viruses. 2014 Mar;8(2):235-42. doi: 10.1111/irv.12184. Epub 2013 Sep 30.

8.

Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses.

Ginting TE, Shinya K, Kyan Y, Makino A, Matsumoto N, Kaneda S, Kawaoka Y.

J Virol. 2012 Jan;86(1):121-7. doi: 10.1128/JVI.06085-11. Epub 2011 Oct 19.

9.

Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63.

Dijkman R, Jebbink MF, Deijs M, Milewska A, Pyrc K, Buelow E, van der Bijl A, van der Hoek L.

J Gen Virol. 2012 Sep;93(Pt 9):1924-9. doi: 10.1099/vir.0.043919-0. Epub 2012 Jun 20.

PMID:
22718567
10.

Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach.

Karthick V, Shanthi V, Rajasekaran R, Ramanathan K.

Appl Biochem Biotechnol. 2012 May;167(2):237-49. doi: 10.1007/s12010-012-9687-7. Epub 2012 Apr 28.

PMID:
22544690
11.

Envelope Proteins Pertain with Evolution and Adaptive Mechanism of the Novel Influenza A/H1N1 in Humans.

Mondal SI, Zubaer A, Thapa S, Saha C, Alum MA, Reza MS, Akter A, Azad AK.

J Microbiol Biotechnol. 2010 Nov;20(11):1500-5.

12.

[Virological impact of stalk region of neuraminidase in influenza A/Anhui/1/05 (H5N1) and A/Ohio/07/2009 (H1N1) viruses].

Wu J, Wang T, Zhang L, Ye ZH, Lv JX.

Bing Du Xue Bao. 2014 May;30(3):238-45. Chinese.

PMID:
25118377
13.

Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.

Meijer A, Jonges M, Abbink F, Ang W, van Beek J, Beersma M, Bloembergen P, Boucher C, Claas E, Donker G, van Gageldonk-Lafeber R, Isken L, de Jong A, Kroes A, Leenders S, van der Lubben M, Mascini E, Niesters B, Oosterheert JJ, Osterhaus A, Riesmeijer R, Riezebos-Brilman A, Schutten M, Sebens F, Stelma F, Swaan C, Timen A, van 't Veen A, van der Vries E, te Wierik M, Koopmans M.

Antiviral Res. 2011 Oct;92(1):81-9. doi: 10.1016/j.antiviral.2011.07.004. Epub 2011 Jul 13.

PMID:
21767571
14.

Transport of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 and Cdc42 proteins.

Wang S, Li H, Chen Y, Wei H, Gao GF, Liu H, Huang S, Chen JL.

J Biol Chem. 2012 Mar 23;287(13):9804-16. doi: 10.1074/jbc.M111.312959. Epub 2012 Feb 8.

15.

Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury.

Yang P, Gu H, Zhao Z, Wang W, Cao B, Lai C, Yang X, Zhang L, Duan Y, Zhang S, Chen W, Zhen W, Cai M, Penninger JM, Jiang C, Wang X.

Sci Rep. 2014 Nov 13;4:7027. doi: 10.1038/srep07027.

16.

Sequence and phylogenetic analyses of neuraminidase gene of Iranian seasonal influenza H1N1 viruses from 2005-2009 and corresponding vaccine strains.

Jandaghi NZ, Azad TM, Nadji SA, Yavarian J, Naseri M, Salimi V, Rad KS, Nategh R.

Acta Virol. 2010;54(3):205-10.

PMID:
20822313
17.

Functional significance of the hemadsorption activity of influenza virus neuraminidase and its alteration in pandemic viruses.

Uhlendorff J, Matrosovich T, Klenk HD, Matrosovich M.

Arch Virol. 2009;154(6):945-57. doi: 10.1007/s00705-009-0393-x. Epub 2009 May 21.

18.

Molecular anatomy of 2009 influenza virus A (H1N1).

Arias CF, Escalera-Zamudio M, Soto-Del Río Mde L, Cobián-Güemes AG, Isa P, López S.

Arch Med Res. 2009 Nov;40(8):643-54. doi: 10.1016/j.arcmed.2009.10.007. Review.

PMID:
20304251
19.

Prediction of biological functions on glycosylation site migrations in human influenza H1N1 viruses.

Sun S, Wang Q, Zhao F, Chen W, Li Z.

PLoS One. 2012;7(2):e32119. doi: 10.1371/journal.pone.0032119. Epub 2012 Feb 15.

20.

Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution.

Rameix-Welti MA, Munier S, Le Gal S, Cuvelier F, Agou F, Enouf V, Naffakh N, van der Werf S.

Antivir Ther. 2011;16(4):597-603. doi: 10.3851/IMP1804.

PMID:
21685548

Supplemental Content

Support Center